An Analysis of Clinical Efficacy Based on the Robotic, Laparoscopic, and Open Approach in Radical Resection of Rectal Cancer

NCT ID: NCT03911167

Last Updated: 2019-04-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

24 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-09-01

Study Completion Date

2018-07-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A retrospective study was done on the medical records for 24 rectal cancer patients underwent robotic proctectomy from September 2017 to July 2018 at the First Affiliated Hospital of Xi'an Jiaotong University.In the same department,a total of 25 patients who treated with laparoscopic proctectomy and 24 patients underwent open proctectomy were were selected as controls in a 1:1:1 ratio. Comparing the perioperative conditions and hospitalization related costs of the three groups.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Rectal Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

RG

RG: robotic group

open, laparoscopic, and robotic

Intervention Type PROCEDURE

Radical resection of rectal cancer in robotic, laparoscopic, and open approach

LG

LG:laparoscopic group,

open, laparoscopic, and robotic

Intervention Type PROCEDURE

Radical resection of rectal cancer in robotic, laparoscopic, and open approach

OG

OG:open group

open, laparoscopic, and robotic

Intervention Type PROCEDURE

Radical resection of rectal cancer in robotic, laparoscopic, and open approach

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

open, laparoscopic, and robotic

Radical resection of rectal cancer in robotic, laparoscopic, and open approach

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* endoscopic biopsy pathological diagnosis of rectal cancer is clear, preoperative CT, MRI examination did not see the tumor directly invaded the surrounding organs;
* blood test, cardiac ultrasound, lung ventilation function and other preoperative examination without absolute surgical contraindications;
* without distant metastasis such as liver, lung, bone, and abdominal cavity.

Exclusion Criteria

* there is distant organ transfer or extensive abdominal metastasis;
* emergency surgery for acute intestinal obstruction, hemorrhage, perforation, intestinal rupture, etc.;
* combined with other primary malignant tumors;
* other colonectomy and combined with other organ resection;
* patients with severe basic diseases unable to tolerate surgery;
* pregnant and lactating women;
* patients who underwent neoadjuvant radiotherapy and chemotherapy before surgery;
* those who underwent palliative surgery.
Minimum Eligible Age

18 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

First Affiliated Hospital Xi'an Jiaotong University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

First Affiliated Hospital of Xi'an Jiaotong University

Xi'an, Shaanxi, China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

XJTU1AF2019LSK-009

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

RATME Vs LATME in Middle and Low Rectal Cancer
NCT06105203 NOT_YET_RECRUITING NA